COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Hemab Therapeutics is a clinical-stage biotechnology company developing first-in-class prophylactic therapies for underserved bleeding and thrombotic disorders.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
